CBO Says FDA User Fee Bill Would Save $358M Over 10 Years

Law360, New York (May 15, 2012, 7:02 PM EDT) -- The Congressional Budget Office said Friday that a Senate bill to reauthorize the U.S. Food and Drug Administration’s user fee programs would reduce direct government spending by $358 million from 2013 to 2022 and could lower drug costs.

The renewed user fees will also bring in $5 million in revenue during that period, the CBO said. Additionally, provisions contained in the bill that would affect when lower-priced drugs become available are also likely to reduce costs, assuming it is approved by the end of the fiscal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.